OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global burden of lung cancer: current status and future trends
Amanda Leiter, Rajwanth Veluswamy, Juan P. Wisnivesky
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 624-639
Closed Access | Times Cited: 526

Showing 1-25 of 526 citing articles:

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray, Mathieu Laversanne, Hyuna Sung, et al.
CA A Cancer Journal for Clinicians (2024) Vol. 74, Iss. 3, pp. 229-263
Open Access | Times Cited: 6308

Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73

Lung cancer in patients who have never smoked — an emerging disease
Jaclyn LoPiccolo, Alexander Gusev, David C. Christiani, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 121-146
Open Access | Times Cited: 66

Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
Pasquale Marino, Mariangela Mininni, Giovanni Deiana, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 800-800
Open Access | Times Cited: 56

European cancer mortality predictions for the year 2024 with focus on colorectal cancer
Claudia Santucci, Silvia Mignozzi, Matteo Malvezzi, et al.
Annals of Oncology (2024) Vol. 35, Iss. 3, pp. 308-316
Open Access | Times Cited: 45

H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer
Zhang Cai, Lijie Zhou, Mingyuan Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3589-3601
Closed Access | Times Cited: 29

Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies
Behnam Najafiyan, Zahra Bokaii Hosseini, Samar Esmaelian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116207-116207
Open Access | Times Cited: 22

Overcoming the Limits of Cross-Sensitivity: Pattern Recognition Methods for Chemiresistive Gas Sensor Array
Haixia Mei, Jingyi Peng, Tao Wang, et al.
Nano-Micro Letters (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20

EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47
Liyang Hu, Weitao Zhuang, Mao-jian Chen, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1186-1200
Closed Access | Times Cited: 15

Multifunctional metal-organic frameworks with photothermal-triggered nitric oxide release for gas/photothermal synergistic cancer therapy
Xingyu Luo, Tian Zhao, Shuheng Qin, et al.
Journal of Colloid and Interface Science (2025) Vol. 684, pp. 47-59
Closed Access | Times Cited: 2

Loss of DDX24 inhibits lung cancer progression by stimulating IKBKG splicing-mediated autophagy
Siwen Sun, Xiaomeng Jing, Guangquan Tong, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1879-1895
Open Access | Times Cited: 1

Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
Emily B. Wolf, Guilherme Sacchi de Camargo Correia, Shenduo Li, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 128-128
Open Access | Times Cited: 1

Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
Ganfeng Luo, Yanting Zhang, Harriet Rumgay, et al.
The Lancet Respiratory Medicine (2025)
Closed Access | Times Cited: 1

Comprehensive insights and In silico analysis into the emerging role of LincRNAs in lung diseases pathogenesis; a step toward ncRNA precision
Nadia Μ. Hamdy, Mohamed Bakr Zaki, Nourhan M. Abdelmaksoud, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Global and China trends and forecasts of disease burden for female lung Cancer from 1990 to 2021: a study based on the global burden of disease 2021 database
B. Li, Yuyan Wu, Yanhong Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access | Times Cited: 1

Deep learning paradigms in lung cancer diagnosis: A methodological review, open challenges, and future directions
Aryan Nikul Patel, Kathiravan Srinivasan
Physica Medica (2025) Vol. 131, pp. 104914-104914
Closed Access | Times Cited: 1

Dual-Locked Fluorescence Probe for Monitoring the Dynamic Transition of Pulmonary Macrophages
Yuxuan Hu, Jing Liu, Mengke Xu, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1

AI-Driven Models for Diagnosing and Predicting Outcomes in Lung Cancer: A Systematic Review and Meta-Analysis
Mohammed Kanan Alshammari, Hajar Alharbi, Nawaf M. Alotaibi, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 674-674
Open Access | Times Cited: 12

Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC
Oraianthi Fiste, Ioannis Gkiozos, Andriani Charpidou, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 831-831
Open Access | Times Cited: 12

Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials
Md. Musavvir Mahmud, Nikhil Pandey, Jeffrey A. Winkles, et al.
Nano Today (2024) Vol. 56, pp. 102314-102314
Closed Access | Times Cited: 12

Advancing Oncology Diagnostics: AI-Enabled Early Detection of Lung Cancer Through Hybrid Histological Image Analysis
Naglaa F. Noaman, Bassam M. Kanber, Ahmad Al Smadi, et al.
IEEE Access (2024) Vol. 12, pp. 64396-64415
Open Access | Times Cited: 11

LncRNA-encoded peptides in cancer
Yaguang Zhang
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11

Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019–2024)
Debasis Das, Lingzhi Xie, Hong Jian
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 11

Design, spectroscopic characterization, in silico and in vitro cytotoxic activity assessment of newly synthesized thymol Schiff base derivatives
Eyüp Başaran, Reşit Çakmak, Dicle Sahin, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top